Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … Schmidt, B. L.. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675512
DOI URL
directSciHub download

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., … Nutt, D. J.. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry

Plain numerical DOI: 10.1016/S2215-0366(16)30065-7
DOI URL
directSciHub download

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A.. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881116675513
DOI URL
directSciHub download

Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., … Nutt, D. J.. (2017). Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms. Scientific Reports

Plain numerical DOI: 10.1038/s41598-017-13282-7
DOI URL
directSciHub download

Patra, S.. (2016). Return of the psychedelics: Psilocybin for treatment resistant depression. Asian Journal of Psychiatry

Plain numerical DOI: 10.1016/j.ajp.2016.08.010
DOI URL
directSciHub download

Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R.. (2017). Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression. Journal of Humanistic Psychology

Plain numerical DOI: 10.1177/0022167817709585
DOI URL
directSciHub download

Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenweider, F. X.. (2015). Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry

Plain numerical DOI: 10.1016/j.biopsych.2014.04.010
DOI URL
directSciHub download

Johnson, M. W., & Griffiths, R. R.. (2017). Potential Therapeutic Effects of Psilocybin. Neurotherapeutics

Plain numerical DOI: 10.1007/s13311-017-0542-y
DOI URL
directSciHub download

Carhart-Harris, R. L., & Goodwin, G. M.. (2017). The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology

Plain numerical DOI: 10.1038/npp.2017.84
DOI URL
directSciHub download

Mahapatra, A., & Gupta, R.. (2017). Role of psilocybin in the treatment of depression. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125316676092
DOI URL
directSciHub download

Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology

Plain numerical DOI: 10.1016/j.neuropharm.2017.12.041
DOI URL
directSciHub download

Stroud, J. B., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D. J., … Carhart-Harris, R. L.. (2018). Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-017-4754-y
DOI URL
directSciHub download

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C.. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology

Plain numerical DOI: 10.1177/2045125316638008
DOI URL
directSciHub download

de Veen, B. T. H., Schellekens, A. F. A., Verheij, M. M. M., & Homberg, J. R.. (2017). Psilocybin for treating substance use disorders?. Expert Review of Neurotherapeutics

Plain numerical DOI: 10.1080/14737175.2016.1220834
DOI URL
directSciHub download

Lyons, T., & Carhart-Harris, R. L.. (2018). Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881117748902
DOI URL
directSciHub download

Roseman, L., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology

Plain numerical DOI: 10.3389/fphar.2017.00974
DOI URL
directSciHub download

Thomas, K., Malcolm, B., & Lastra, D.. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs

Plain numerical DOI: 10.1080/02791072.2017.1320734
DOI URL
directSciHub download

Geiger, H. A., Wurst, M. G., & Daniels, R. N.. (2018). DARK Classics in Chemical Neuroscience: Psilocybin. ACS Chemical Neuroscience

Plain numerical DOI: 10.1021/acschemneuro.8b00186
DOI URL
directSciHub download

Young, S. N.. (2013). Single treatments that have lasting effects: Some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Journal of Psychiatry and Neuroscience

Plain numerical DOI: 10.1503/jpn.120128
DOI URL
directSciHub download

Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart-Harris, R. L.. (2018). Effects of psilocybin therapy on personality structure. Acta Psychiatrica Scandinavica

Plain numerical DOI: 10.1111/acps.12904
DOI URL
directSciHub download